HRS-6209
N/A
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameHRS-6209
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesAtridia Pty LtdShandong Shengdi Pharmaceutical Co LtdShanghai Hengrui Pharmaceutical Co Ltd +[5]
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A